Telmisartan

Is telmisartan effective in treating non-alcoholic steatohepatitis?

Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) are well-recognized causes of progressive liver disease leading to cirrhosis and hepatocellular carcinoma. To date, no therapy provided evidence of significant efficacy in these conditions and no approved therapeuti...

Global study shows telmisartan reduces outcome of cardiovascular death, heart attack or stroke

HAMILTON August 31, 2008 -- An international study led by Canadian researchers has found that telmisartan, a medication used to lower blood pressure, reduced the outcome of cardiovascular death, heart attack or stroke in people who are unable to tolerate a widely available and effective standard ...

Newer Blood Pressure Drug Better for Some Heart Patients, Diabetics

... Study found telmisartan offered slight benefit for those unable to take AC...t the angiogenesis-receptor blocker (ARB) known as telmisartan worked well for the 20 percent of patients with va...vascular disease or high-risk diabetes took either telmisartan or a placebo, and were followed for almost five ye...

Newer Blood Pressure Drug No Better Than Placebo in Preventing Stroke

... Patients may need to be on telmisartan longer to see positive effect, researchers say ...ug. 27 (HealthDay News) -- The blood pressure drug telmisartan does not lower the rate of stroke, cardiovascular ...ients who have had a stroke, a new study finds. telmisartan is an angiotensin II receptor blocker, which works...

ACE Inhibitor as Effective as More Expensive Blood Pressure Drug

...ith the widely used ACE inhibitor ramipril (Altace) and those given the ARB telmisartan (Micardis). "This is the first study in such a population that shows ACE...wo groups -- 16.5 percent for those taking ramipril and 16.7 percent in the telmisartan group. It was also about the same in a group prescribed both medications, 1...

Telmisartan in Medical Technology

New Study Shows That telmisartan has Greater Renoprotective Potential Thanlosartan in Hypertensive Patients With Type 2 Diabetes

MILAN, Italy, June 15 /CNW/ - Today AMADEO, one of the first studies to compare the protective potential of two angiotensin receptor blockers in hypertensive patients with diabetic nephropathy, was presented at the European Society of Hypertension, Milan. The results from this study show that ...

TRANSCEND(TM) Trial Results Presented at European Society of Cardiology Congress and Published in The Lancet

...ial. "Previously, the ONTARGET trial showed that telmisartan was as effective as the ACE inhibitor ramipril in ...r hospitalizations were significantly reduced with telmisartan (894 vs. 980; p=0.025). Therapy with telmisartan w... discontinuation (640 patients discontinued taking telmisartan vs. 707 taking placebo, p=0.051). The most frequen...

PRoFESS(R) Results Announced at XVII European Stroke Conference

...t between academia and the sponsor, Boehringer Ingelheim. Co-funders of the telmisartan arm of the study in selected countries are Bayer Schering Pharma and GlaxoS...please visit http://www.aggrenox.com . About Micardis(R) (telmisartan) telmisartan is marketed in the United States by Boehringer Ingelheim as MICARDIS(R) tab...

Landmark ONTARGET(TM) Trial Demonstrates Micardis(R) is Equally Effective as Ramipril, with Fewer Discontinuations, in a Broad High-Risk Cardiovascular Population

... Results of ONTARGET (ONgoing telmisartan Alone and in combination with Ramipril Global End...) was 1.01, with a 95 percent CI of 0.94 - 1.09. telmisartan is now the only ARB to have demonstrated cardio an...was prevented.(2) "The ONTARGET trial shows that telmisartan is a well-tolerated treatment in high-risk cardiov...

New Data Presented on Micardis (Telmisartan) Tablets in Hypertensive Patients With Type 2 Diabetes

...d-titration, multicenter, parallel group, 1-year treatment trial to compare telmisartan 40 mg titrated to 80 mg versus losArtan 50 mg titrated to 100 mg, in hypert...ger-ingelheim.com . References (1) Burgess E et al. Efficacy of telmisartan compared with losartan in reducing proteinuria in hypertensive typ...

Telmisartan in Biological News

Blood pressure drug telmisartan shows powerful activity against stroke

NEW YORK (Dec. 12, 2007) -- Telmisartan, a drug widely used to help control blood pressure, may have uniquely potent activity in preventing stroke, according to a new study conducted in an animal model. Whether they used the drug alone or in combination with a different type of antihypertensive...